NAT10 as a potential prognostic biomarker and therapeutic target for HNSCC.
Wenjie TaoGuocai TianShengming XuJiayi LiZhiyuan ZhangJiang LiPublished in: Cancer cell international (2021)
NAT10 could be a potential prognostic marker and a therapeutic target for HNSCC.
Keyphrases